Companies: 10,795·Total market cap: $144.5T
Eyenovia, Inc.

Eyenovia, Inc.

EYENNASDAQHealthcare
$7.56
+$0.29(+3.99%)
Market Cap$38588962
P/E Ratio
52W High$124.8
52W Low$0.85
SEC Filings

Eyenovia, Inc. (EYEN) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001682639 · EYEN · NASDAQ · as of Jun 9, 2026

Filing snapshot

599
Total Filings
8-K
Latest Form
2026-06-05
Most Recent
2018
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001682639 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-30
Fiscal Year End
Mar 30, 2026
Accession No.
0001104659-26-036286
Primary Document
hypd-20251231x10k.htm
Source: data.sec.gov · CIK 0001682639 · Accession 0001104659-26-036286

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-15
8-KCurrent Report
FORM 8-K
2026-06-05Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-06-05
View
10-QQuarterly Report
10-Q
2026-05-15
View
8-KCurrent Report
FORM 8-K
2026-05-14
View
8-KCurrent Report
FORM 8-K
2026-05-06
View
424B5424B5
424B5
2026-05-06
View
ARSARS
ARS
2026-05-05
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-05-05
View
DEF 14AProxy Statement
DEF 14A
2026-05-05
View
424B5424B5
424B5
2026-05-05
View
PRE 14APRE 14A
PRE 14A
2026-04-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-01
View
10-KAnnual Report
10-K
2026-03-30
View
8-KCurrent Report
FORM 8-K
2026-03-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-03
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-11
View
Showing 1–15 of 396 filingsForm 4 / 144 hidden· 599 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001682639  |  Exchange: NASDAQ · Healthcare

Eyenovia, Inc. (NASDAQ: EYEN) has submitted 599 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001682639, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Eyenovia, Inc.'s most comprehensive regulatory disclosure. The most recent Eyenovia, Inc. 10-K was filed on 2026-03-30 for fiscal year ending 2026. Historical EYEN 10-K annual reports are available from 2016 through 2026.

Investors researching Eyenovia, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

EYEN SEC Filings · 8 questions

Eyenovia, Inc. (EYEN) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 599 filings and access original documents at no cost. Eyenovia, Inc.'s CIK is 0001682639.

EYEN SEC filingsEyenovia, Inc. SEC documentsfind EYEN 10-K